Data Sheet ABILIFYTM - Medsafe
NZ_DS_Abilify_V2.1_ August2016 - 2 - PHARMACOLOGY Pharmacodynamics The mechanism of action of ABILIFYTM, as well as other drugs having efficacy in schizophrenia and bipolar disorder, is unknown.
Download Data Sheet ABILIFYTM - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Managing Depression Using Rational Emotive …
albertellis.orgREBT Depression Manual/Protocol – BBU, David et al., (2004) 1 Managing Depression Using Rational Emotive Behavior Therapy (REBT) To be Used Free for Research, Educational, and Training Purposes
Treatment Planning - Integrated Recovery
integratedrecovery.orgTreatment Planning I N T R O D U C T I O N Treatment planning is a collaborative process of working with a client and his family or support system to specify personal goals and the means by
CHAPTER The Psychiatric Nursing Assessment
www.jblearning.com40 CHAPTER 3 The Psychiatric Nursing Assessment Introduction The evaluation of psychiatric clients is a multifac-eted endeavor, most effectively performed by an ...
PRODUCT INFORMATION NAME OF THE MEDICINE
www.medicines.org.auSEROQUEL XR® Product Information Doc ID-000505115 V26 2(46) PHARMACOLOGY Mechanism of Action Quetiapine is an atypical antipsychotic agent. …
A-level PSYCHOLOGY (7182/3) - filestore.aqa.org.uk
filestore.aqa.org.ukLouise comes from a family with a history of schizophrenia, as both her grandfather and an aunt have been diagnosed with the disorder. Louise’s father